Clinical trial
Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone…
NCT00216892 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00216892 |
|---|---|
| Title | Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris |
| Official title | Different Treatment Regimens of Calcipotriol Cream and Combination (Calcipotriol/Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psoriasis Vulgaris |
| Intervention type | Drug |
| Interventions | Calcipotriol, (calcipotriol + betamethasone) |
| Enrollment | 1,032 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 24, 2025 |
| Countries | Belgium, Canada, France, Germany, Netherlands, Spain, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: